Blood cancers

Treatment free remission is a realistic goal in CML: new guidelines

New recommendations for management of CML have emphasised the goal of treatment free remission (TFR). In a substantial update from their 2013 recommendations, a European LeukemiaNet panel of experts including Australian Professor Timothy Hughes said a significant proportion of patients will achieve a deep molecular response (DMR) with the familiar TKIs. “An attempt at treatment ...

Already a member?

Login to keep reading.

© 2021 the limbic